![]() 2[4[(4-硝基苯基)甲氧基]苯基]甲基磺酸乙酯结构式
![]() |
常用名 | 2[4[(4-硝基苯基)甲氧基]苯基]甲基磺酸乙酯 | 英文名 | 2-[4-[(4-Nitrophenyl)methoxy]phenyl]ethyl Ester Carbamimidothioic Acid |
---|---|---|---|---|
CAS号 | 182004-64-4 | 分子量 | 427.50 | |
密度 | 1.52±0.1 g/cm3 | 沸点 | 98.4±23.0 °C | |
分子式 | C16H17N3O3S | 熔点 | N/A | |
MSDS | N/A | 闪点 | 277.1±32.9 °C |
中文名 | 2[4[(4-硝基苯基)甲氧基]苯基]甲基磺酸乙酯 |
---|---|
英文名 | KB-R7943 |
英文别名 | 更多 |
密度 | 1.52±0.1 g/cm3 |
---|---|
沸点 | 98.4±23.0 °C |
分子式 | C16H17N3O3S |
分子量 | 427.50 |
闪点 | 277.1±32.9 °C |
精确质量 | 331.099060 |
LogP | 3.23 |
外观性状 | powder |
蒸汽压 | 0.0±1.4 mmHg at 25°C |
折射率 | 1.629 |
储存条件 | 2-8°C |
水溶解性 | DMSO: >10mg/mL |
Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.
Eur. J. Heart Fail. 16(4) , 358-66, (2015) Doxorubicin is widely used against cancer; however, it can produce heart failure (HF). Among other hallmarks, oxidative stress is a major contributor to HF pathophysiology. The late INa inhibitor rano... |
|
Endothelial Angiogenesis and Barrier Function in Response to Thrombin Require Ca2+ Influx through the Na+/Ca2+ Exchanger.
J. Biol. Chem. 290 , 18412-28, (2015) Thrombin acts on the endothelium by activating protease-activated receptors (PARs). The endothelial thrombin-PAR system becomes deregulated during pathological conditions resulting in loss of barrier ... |
|
Digoxin and adenosine triphosphate enhance the functional properties of tissue-engineered cartilage.
Tissue Eng. Part A 21(5-6) , 884-94, (2015) Toward developing engineered cartilage for the treatment of cartilage defects, achieving relevant functional properties before implantation remains a significant challenge. Various chemical and mechan... |
K168065 |
2-{4-[(4-Nitrobenzyl)oxy]phenyl}ethyl carbamimidothioate |
Carbamimidothioic acid, 2-[4-[(4-nitrophenyl)methoxy]phenyl]ethyl ester |
carbamimidothioic acid 2-[4-[(4-nitrophenyl)methoxy]phenyl]ethyl ester |